No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Contraindications
-
Drug Therapy, Combination
-
Hepacivirus / isolation & purification
-
Hepatitis B virus / isolation & purification
-
Hepatitis B, Chronic / drug therapy*
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Interferon Type I / administration & dosage*
-
Interferon Type I / adverse effects
-
Interferon alpha-2
-
Interferon-alpha* / therapeutic use
-
Lamivudine / administration & dosage
-
Lamivudine / adverse effects
-
Polyethylene Glycols*
-
Practice Guidelines as Topic
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Reverse Transcriptase Inhibitors / therapeutic use*
-
Ribavirin / administration & dosage
-
Ribavirin / adverse effects
Substances
-
Antiviral Agents
-
Interferon Type I
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Reverse Transcriptase Inhibitors
-
Lamivudine
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2b
-
peginterferon alfa-2a